Cargando…

COVID-19: A hematological perspective

Detalles Bibliográficos
Autores principales:	Nayak, Lalitha, Zheng, Ze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633637/ https://www.ncbi.nlm.nih.gov/pubmed/36494151 http://dx.doi.org/10.1016/j.beha.2022.101412

Ejemplares similares

Editorial: Women in Science—Hematology 2021
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
por: Velazquez Manana, Ana I., et al.
Publicado: (2020)

Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India
por: Jain, Arihant, et al.
Publicado: (2022)

COVID-19 in hematology: data from a hematologic and transplant unit
por: Garnica, Marcia, et al.
Publicado: (2020)

Hematological features of persons with COVID-19
por: Li, Qiubai, et al.
Publicado: (2020)

COVID-19: Review and hematologic impact
por: Letícia de Oliveira Toledo, Sílvia, et al.
Publicado: (2020)

Epigenetics in Cancer: A Hematological Perspective
por: Stahl, Maximilian, et al.
Publicado: (2016)

Is COVID-19 a New Hematologic Disease?
por: Debuc, Benjamin, et al.
Publicado: (2020)

Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment
por: Durani, Urshila, et al.
Publicado: (2022)

Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective
por: Ali, Syed Saqib, et al.
Publicado: (2022)

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

COVID-19 in Patients with Hematologic Diseases
por: Casetti, Ilaria Carola, et al.
Publicado: (2022)

Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment
por: Durani, Urshila, et al.
Publicado: (2020)

Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
por: Guo, Wenjing, et al.
Publicado: (2023)

Are Hematologic Patients Trojan Horse for COVID-19?
por: Kılıçaslan, Emrah, et al.
Publicado: (2021)

Hematological changes associated with COVID‐19 infection
por: Al‐Saadi, Enass Abdul Kareem Dagher, et al.
Publicado: (2021)

Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Hematological Abnormalities in COVID-19: A Narrative Review
por: Rahman, Asma, et al.
Publicado: (2021)

Hematologic disorders associated with COVID-19: a review
por: Rahi, Mandeep Singh, et al.
Publicado: (2021)

Nosocomial Outbreak of COVID-19 in a Hematologic Ward
por: Jung, Jiwon, et al.
Publicado: (2021)

Covid-19 Infection in Hematological Malignancies: Registry Data from India
por: Jain, Arihant, et al.
Publicado: (2021)

Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives
por: Giles, Grace, et al.
Publicado: (2022)

COVID-19 Vaccines and Autoimmune Hematologic Disorders
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

COVID-19 outcomes in patients with hematologic disease
por: Malard, Florent, et al.
Publicado: (2020)

COVID-19 in Hematologic Malignancies: Big Challenges
por: Hu, Yongxian, et al.
Publicado: (2020)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

The outcome of COVID-19 in patients with hematological malignancy
por: Tığlıoğlu, Pınar, et al.
Publicado: (2021)

Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19
por: Levi, Marcel
Publicado: (2021)

Hematological alterations associated with long COVID-19
por: Lechuga, Guilherme C., et al.
Publicado: (2023)

Hematologic Complications in Patients Hospitalized with COVID-19 Infection
por: Lin, Elisa, et al.
Publicado: (2022)

Redox stress in COVID-19: Implications for hematologic disorders
por: Yang, Moua
Publicado: (2022)

The clinical impact of COVID-19 epidemic in the hematologic setting
por: Finelli, Carlo, et al.
Publicado: (2020)

A Review of Hematological Complications and Treatment in COVID-19
por: Yazdani, Armand N., et al.
Publicado: (2023)

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
por: Pagano, Livio, et al.
Publicado: (2021)

Covid-19 and Suspected Covid-19 Patients Rapidly Diagnosed with Unusual Pathogens by Hematology Body Fluid Review: Cytology’s Role in the Hematology Section
por: Green, Linda, et al.
Publicado: (2021)

Changes of hematological and immunological parameters in COVID-19 patients
por: Yuan, Xiaohong, et al.
Publicado: (2020)

Hematological and Inflammatory Parameters to Predict the Prognosis in COVID-19
por: Keski, Hakan
Publicado: (2021)

Role of Hematological and Immunological Parameters in COVID-19 Patients
por: Kumar, Avanindra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jddfkvng5di0q5qcpnggi3c8ln